Form EFFECT XORTX Therapeutics Inc.
Tweet
Share
E-mailGet instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 30, 2022 |
| Accession Number: | 0001104659-22-104261 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- XORTX Therapeutics Inc (XRTX) Files $50M Mixed Shelf
- This Week in Energy News: 11 Stories You Need to See
- Real Matters Reports First Quarter Financial Results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
